AstraZeneca Denies Vaccine Trial Subject Had Nerve Ailment

(Bloomberg) -- AstraZeneca Plc, the drugmaker working with the University of Oxford on a Covid-19 vaccine, contradicted a report that a volunteer in U.K. tests of the shot developed a rare nerve di...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.